Posts Tagged ‘DreamPort’

DreamPort™ and Research

Wednesday, September 9th, 2009

About Sleep Apnea:

According to the National Institutes of Health, 50 to 70 million Americans are affected by chronic sleep disorders which can significantly diminish health, alertness and safety. An estimated 18 million Americans have sleep apnea, one of the most common sleep disorders. Yet, many sufferers are undiagnosed. Untreated sleep disorders can lead to hypertension, heart disease, stroke, depression, diabetes and other chronic disorders. In order for sleep apnea to be diagnosed, a patient normally undergoes a polysomnography (PSG), which is a noninvasive, pain-free procedure that usually requires spending a night in a sleep lab. During a PSG study, a sleep technologist records multiple biological functions during sleep, such as brain wave activity, eye movement, muscle tone, heart rhythm and breathing using electrodes and monitors placed on the head, chest and legs.

About DreamPort:

CleveMed recently introduced DreamPort, an accessory to CleveMed’s Sapphire PSG (full PSG wireless system). Using broadband technology and built-in camera, DreamPort is a gateway to transmit full PSG data from the patient’s location to a sleep lab, thus, allowing remote attendance for patients who may be anxious or incapable of attending a sleep lab. With this new emerging medical device technology, diagnosing and treating sleep disorders has become timelier.

Why DreamPort is Suitable for Clinical Trials:

DreamPort is suitable for clinical trials as it allows for cost effective research studies to be conducted nearly anywhere. According to Cutting Edge Information, the average drug company spends about 37% of their overall R&D budgets on clinical trials. The average per-patient cost of clinical trials ranges roughly from $5,500 $7,6001. Typical clinical trials follow a set of rules called a protocol and are managed by doctors. The studies are commonly run by nurses or other health care professionals2. Now, DreamPort gives clinicians and researchers greater flexibility to conduct clinical trials where the patient is. Researchers and clinicians are able to obtain new types of research, like location specific research -home, hotel, hospital or lab; which can lead to support and establish a wider patient base.

The cost of home testing is a fraction of the cost of in-lab testing and can be less than the cost of using personnel for a full night sleep study. The average in-lab sleep studies cost range between $1,000-$5,000 a night. The cost of home studies range 35% to 88% lower than in-lab studies. The lower cost of home sleep studies makes DreamPort a practicable screening tool to collect meaningful research for patients with suspected sleep disorders, like Obstructive Sleep Apnea (OSA).3

This post draws on the experience of CleveMed professionals and professionals in the Sleep Disorder industry.

1 “Per Patient Clinical Trials Cost $5,500+” PR Newswire (2005). Goliath: Business Knowledge on Demand. PR Newswire http://goliath.ecnext.com/coms2/gi_0199-3658846/Per-Patient-Clinical-Trials-Cost.html. 2 United States Department of Veterans Affairs. 3 Laboratory versus portable sleep studies: A meta-analysis. Rep. 2006. Department of Otolaryngology-Head and Neck Surgery, Medical University of South Carolina, Charleston, South Carolina.Wiley-Blackwell.

DreamPort ushers in
concept of attended PSG Anywhere

Thursday, September 3rd, 2009

CleveMed’s DreamPort, expands the reach of your sleep business by allowing remotely attended sleep studies to be done from anywhere, using a bedside system controlled by sleep technologists miles away – over the internet. Broadband technology combined with a camera is used to transmit the patient data and video in real-time, allowing studies to be conducted anywhere the patient is.

  • DreamPort is particularly ideal for those who are unable or reluctant to make it into the sleep lab, such as pediatric patients, cross country truckers, the elderly, those suffering from chronic pain and hospital inpatients.
  • In addition, this system gives clinicians and researchers greater flexibility to conduct sleep studies anywhere. DreamPort is suitable for clinical trials as it allows for cost effective research studies to be conducted in the patient’s home while adding an additional element of home care.
  • DreamPort combines the comfort and cost-effectiveness of home testing with the peace of mind of an attended study.
  • Dr. Golish, is a board-certified specialist in sleep medicine and author of more than 300 publications on sleep. He is a member of the Sleep Steering Committee for the ACCP. After 35 years as a professor in The Cleveland Clinic and Co-Director of Sleep Medicine, he has left academic medicine to advance a new paradigm in sleep medicine, focusing on accessibility and affordability. His goals are the proper use of HST and fostering continuity of care, in an efficient and cost-effective manner, while preserving high quality. He is currently the Medical Director of Cleveland Medical Devices (CleveMed) and Director of Sleep Center, North Coast Clinical Trials, in Cleveland, Ohio.

    Live Remotely Attended Sleep Studies
    at Sleep 2009

    Friday, July 10th, 2009


    CleveMed’s DreamPort was recently launched at Sleep 2009 in Seattle, WA:

    DreamPort expands the reach of your sleep lab by allowing remotely attended sleep studies to be done from anywhere using a bedside system controlled by sleep lab technologists miles away - over the internet!

    CleveMed showcased this innovative product with a Live Remotely Attended Sleep Study! A patient located in Cleveland, Ohio was hooked up to a Sapphire PSG which wirelessly transmitted the real time data to the DreamPort located in the patient’s room. Using the camera and broadband technology that the DreamPort provides, the patient’s full PSG data was viewed live by sleep technicians in Seattle, Washington at Sleep 2009!

    DreamPort Benefits:

    DreamPort is especially ideal for those who are unable to make it into the sleep lab, such as pediatric patients, cross country truckers, the elderly, those with chronic pain and hospital inpatients. In addition, this system gives clinicians and researchers greater flexibility to conduct sleep studies in anyplace. DreamPort is suitable for clinical trials as it allows for cost effective research studies to be conducted in the patient’s home while adding an additional element of home care. Moreover, DreamPort is easy to use. The small, portable and single-button design simplifies the overall process and deployment.

    DreamPort’s Easy Process:

    Step 1: Patient is hooked up with Sapphire PSG
    Step 2: Patient pushes power button on DreamPort
    Step 3: Sleep tech remotely starts study from sleep lab
    Step 4: Sleep tech controls video and full PSG data remotely

    Broadband technology combined with a camera is used to transmit the patient’s full PSG data and video to technologists in real-time, allowing studies to be conducted anywhere the patient is.

    CleveMed at Sleep 2009

    Monday, June 8th, 2009

    The CleveMed Sleep Team is at Sleep 2009 in Seattle, WA at Booth #929. Doors opened just a few hours ago and the team is very excited to present the pioneering concept of PSG Anywhere to expand the reach of your sleep services.

    Stop by and meet the team at Booth #929. And while you’re there, fill out a card for your chance to win an Amazon Kindle! The drawing for the winning card will be held at noon on Wednesday (June 10, 2009).

    CleveMed will also be launching DreamPort (coming soon), which expands the reach of your sleep by allowing remotely attended sleep studies to be done from virtually anywhere –over the internet! For the first time, the technologist can remotely monitor the patient data and video in real-time from almost any location using an extremely user-friendly and portable bedside system. DreamPort is ideal for testing patients who may have difficulty coming to the sleep lab and allows for cost effective research studies in patient homes.

    Make sure to follow CleveMed at Sleep 2009 on Twitter at http://twitter.com/CleveMed. Check out what a fellow-tweeter said: ikg_agent@CleveMed Much victory…Booth #929 the way of the future :)